Tenascin-C expression in invasion border of early breast cancer: A predictor of local and distant recurrence

British Journal of Cancer

Volumn 78, Issue 11, 1998, Pages 1507-1513

  Jahkola, T ^a   Toivonen, T ^b   Virtanen, I ^c   Von Smitten, K ^a   Nordling, S ^d   Von Boguslawski, K ^d   Haglund, C ^a   Nevanlinna, H ^a   Blomqvist, C ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KYMENLAAKSO CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Breast conserving surgery; Early breast cancer; Local recurrence; Metastasis; Tenascin C

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TENASCIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CELL CYCLE S PHASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE NEU; PLOIDY; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031770515     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.714     Document Type: Article

References (37)

1. Bloom HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359-377
2. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J and Bartelink H (1994) Risk factors in breast-conservation therapy. J Clin Oncol 12: 653-660
3. Boyages J, Recht A, Connolly JL, Schnitt SJ, Gelman R, Kooy H, Love S, Osteen RT, Cady B, Silver B and Harris JR (1990) Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol 19: 29-41
4. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T and McGuire WL (1989) Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 320: 627-633
5. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS and Corbett PJ (1992) Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683-689
6. EBCTCG (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group [see comments]. Lancet 339: 1-15 and 71-85
7. EBCTCG (1995) Effects of radiotherapy and surgery in early breast cancer. N Engl J Med 333: 1444-1455
8. Ferguson JE, Schor AM, Howell A and Ferguson MW (1990) Tn-C distribution in the normal human breast is altered during the menstrual cycle and in carcinoma. Differentiation 42: 199-207
9. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL and Cronin WM (1995) Renalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456-1461
10. Fisher ER, Costantino J, Fisher B, Redmond C and CNSABaBP Investigators (1993). Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) - Discriminants for 15-year survival. Cancer 71: 2141-2150
11. Gage I, Schnitt SJ, Nixon AJ, Silver B, Recht A, Troyan SL, Eberlein T, Love SM, Gelman R, Harris JR and Connolly JL (1996) Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78: 1921-1928
12. Gelber RD and Goldhirsch A (1944) Radiotherapy to the conserved breast: is it avoidable if the cancer is small? J Natl Cancer Inst 86: 652-654
13. Haffty BG, Fisher D, Rose M, Beinfield M and McKhann C (1991) Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. J Clin Oncol 9: 997-1003
14. Hedley DW, Friedlander ML, Taylor IW, Rugg CA and Musgrove EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335
15. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JHCL, Verbeek ALM, Schnitt SJ, Silver B, Boyages J and Harris JR (1990) The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8: 113-118
16. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK and Gould VE (1990) Differential distribulion of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest 63: 798-806
17. Huuhtanen R, Wiklund T, Blomqvist C, Virolainen M, Yi P and Tribukait B (1996) High S-phase fraction is an adverse prognostic sign in diploid soft-tissue sarcomas. Cancer 77: 1815-1822
18. Ishihara A, Yoshida T, Tamaki H and Sakakura T (1995) Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance. Clin Cancer Res 1: 1035-1041
19. Jahkola T, Toivonen T, Von Smitten K, Blomqvist C and Virtanen I (1996) Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer (Pred Oncol) 69: 445-447
20. Jones PL, Cowan KN and Rabinovitch M (1997) Tenascin-C, proliferation and subendothelial fibronectin in progressive pulmonary vascular disease. Am J Pathol 150: 1349-1360
21. Lightner VA, Marks JR and McCachren SS (1994) Epithelial cells are an important source of tenascin in normal and malignant human breast tissue. Exp Cell Res 210: 177-184
22. Liljegren G, Holmberg L, Adami H-O, Westman G, Graffman S and Bergh J (1994) Sector resection with or without postoperative radiotherapy for stage I breast cancer. Five year results of a randomized trial. J Natl Cancer Inst 86: 717-722
23. Mansour EG, Ravdin PM and Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 74: 381-400
24. Morrow M, Harris JR and Schnitt SJ (1995) Local control following breast-conserving surgery for invasive cancer: results of clinical trials. J Natl Cancer Inst 87: 1669-1673
25. Ravdin PM and Chamness GC (1995) The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene 159: 19-27
26. Rosen PP, Lesser ML, Arroyo CD, Cranor M, Borgen P and Norton L (1995) p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J Clin Oncol 13: 821-830
27. Sakakura T, Ishihara A and Yatani R (1991) Tn-C in mammary gland development: from embryogenesis to carcinogencsis. In Regulatory Mechanisms in Breast Cancer, Lippman ME (ed.) pp. 383-400. Advances in Cellular and Molecular Biology of Breast Cancer. Kluwer Academic Publishers: Boston
28. Schnitt SJ, Connolly JL, Khettry U, Mazoujian G, Brenner M, Silver B, Recht A, Beadle G and Harris JR (1987) Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 59: 675-681
29. Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, Osteen, RT, Nixon AJ, Pierce S, Connolly JL, Cohen P, Schneider L, Silver, B, Recht A and Harris JR (1996) A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77: 1094-1100
30. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Fronzo GD and Veronesi U (1993) p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85: 965-970
31. Silvestrini R, Daidone MG, Luisi A, Boracchi P, Mezzetti M, Fronzo GD, Andreola S, Salvadori B and Veronesi U (1995) Biologic and clinicopathological factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol 13: 697-704
32. Tiitta O, Wahlström T, Paavonen J, Linnala A, Sharma S, Gould VE and Virtanen I (1992) Enhanced tenascin expression in cervical and vulvar koilocytotic lesions. Am J Pathol 141: 907-913
33. Veronesi U, Luini A, Vecchio MD, Greco M, Galimberti V, Merson M, Rilke R, Sacchini V, Saccozzi R, Savio T, Zucali R, Zurrida S and Salvadori B (1993) Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328: 1587-1591
34. Veronesi U, Marubini E, Vecchio MD, Manzari A, Andreola S, Greco M, Luini A, Merson M, Saccozzi R, Rilke F and Salvadori B (1995) Local recurrences and distant metastasis after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87: 19-27
35. Victorzon M, Roberts PJ, Haglund C, von Boguslawski K and Nordling S (1996) Ki-67 immunoreactivity, ploidy and S-phase fraction as prognostic factors in patients with gastric carcinoma. Oncology 53: 182-191
36. Whelan T, Clark R, Roberts R, Levine M, Foster G and IotOCO Group (1994) Ipsilateral breast tumour recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Int J Radiat Oncol 30: 11-6
37. Yoshida T, Ishihara A, Hirokawa Y, Kusakabe M and Sakakura T (1995) Tenascin in breast cancer development - is epithelial tenascin a marker for poor prognosis. Cancer Lett 90: 65-73